Peter K. Gillman
Bucasia, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
MAOI Antidepressants: A History Being Rewritten.
Journal: The Journal of clinical psychiatry
Published: December 03, 2025
Monoamine oxidase inhibitors: A paradigm of poor science.
Journal: Journal of psychopharmacology (Oxford, England)
Published: October 04, 2025
Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.
Journal: CNS drugs
Published: April 29, 2025
Serotonin Syndrome with Propofol and Remifentanil: Mechanistic Concern and Alternative Diagnosis.
Journal: A&A practice
Published: December 05, 2024
Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine.
Journal: Journal of psychoactive drugs
Published: June 21, 2024
Expert Opinion on Anesthetic Considerations For Patients Receiving a Classic Monoamine Oxidase Inhibitor.
Journal: Anesthesia and analgesia
Published: February 19, 2024
Classics in Chemical Neuroscience: Selegiline, Isocarboxazid, Phenelzine, and Tranylcypromine.
Journal: ACS chemical neuroscience
Published: November 15, 2023
On the Origins of MAOI Misconceptions: Reaffirming their Role in Melancholic Depression.
Journal: Psychopharmacology bulletin
Published: August 21, 2023
A five-pronged critique of 'Serotonin syndrome-A focused review'.
Journal: Basic & clinical pharmacology & toxicology
Published: July 16, 2023
Classic Monoamine Oxidase Inhibitors for Depression: Update on Nursing Care.
Journal: Issues in mental health nursing
Published: December 05, 2022
The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression.
Journal: CNS spectrums
Published: July 15, 2022
Last Updated: 09/26/2026